- UroToday Home
- Pelvic Health & Reconstruction
The Latest Research in Overactive Bladder
Recent Abstracts
-
Long-term treatment of older patients with overactive bladder using a combination of mirabegron and solifenacin: a prespecified analysis from the randomized, phase III SYNERGY II study.Overactive BladderJanuary 20, 2019
-
Overactive urinary bladder in elderly female patients: treatment specificities and drug interactions.Overactive BladderJanuary 20, 2019
-
Effectiveness and persistence of mirabegron as a first-line treatment in patients with overactive bladder in real-life practice.Overactive BladderJanuary 13, 2019
-
Prevalence, Risk Factors, and Treatment for Overactive Bladder in a Racially Diverse Population.Overactive BladderJanuary 6, 2019
-
Risk factors for persistent, de novo and overall overactive bladder syndrome after surgical prolapse repair.Overactive BladderJanuary 6, 2019
-
Mirabegron, alone and in combination, in the treatment of overactive bladder: real-world evidence and experience.Overactive BladderDecember 30, 2018
-
Higher urge severity score predicts resumption of overactive bladder (OAB) medication following discontinuation of mirabegron treatment in patients with OAB.Overactive BladderDecember 30, 2018
-
Factors influencing return for maintenance treatment with Percutaneous Tibial Nerve Stimulation for the management of the overactive bladder.Overactive BladderDecember 30, 2018
-
Audiovisual stimulus during urodynamics to provoke detrusor overactivity: A randomized trial.Overactive BladderDecember 23, 2018
-
Real-world persistence and adherence to oral antimuscarinics and mirabegron in patients with overactive bladder (OAB): a systematic literature review.Overactive BladderDecember 23, 2018
Beyond the Abstracts
-
A Prospective, non-intErventional Registry Study of PatiEnts initiating a Course of drug Therapy for overactIVE bladder (PERSPECTIVE): Rationale, Design, and Methodology– Beyond the AbstractOveractive BladderJune 11, 2018
-
Association Between Coronary Artery Disease Severity and Overactive Bladder in Geriatric Patients: Beyond the AbstractOveractive BladderOctober 27, 2017
-
Use of Third Line Therapy for Overactive Bladder in a Practice with Multiple Subspecialty Providers: Beyond the AbstractOveractive BladderOctober 13, 2017
-
What is the true catheterization rate after intravesical onabotulinumtoxinA injection: Beyond the AbstractOveractive BladderAugust 23, 2017
-
Real-Time Changes in Brain Activity During Sacral Neuromodulation for Overactive Bladder: Beyond the AbstractOveractive BladderJuly 25, 2017
-
Impact of intravesical onabotulinumtoxinA on sexual function in women with OAB: Beyond the AbstractOveractive BladderJanuary 26, 2017
-
Readability Analysis of Online Health Information about Overactive Bladder: Beyond the AbstractOveractive BladderJanuary 18, 2017
-
Therapeutic potential of human chorionic gonadotropin against overactive bladder - Beyond the AbstractOveractive BladderJanuary 18, 2016
-
Real-World Patterns of Care for the Overactive Bladder (OAB) Syndrome in the United States - Beyond the AbstractOveractive BladderOctober 15, 2015
-
Overactive bladder syndrome, detrusor overactivity and the botulinum toxin - Beyond the AbstractOveractive BladderAugust 31, 2015
